| Característica |
Objectiu de la convocatòria
The Horizon Europe Health Cluster funds collaborative projects and complementary actions through different topics.
|
Característiques principals
Topics:
Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders -
HORIZON-HLTH-2024-DISEASE-03-13
Tackling high-burden for patients, under-researched medical conditions -
HORIZON-HLTH-2024-DISEASE-03-14
Comparative effectiveness research for healthcare interventions in areas of high public health need -
HORIZON-HLTH-2024-DISEASE-03-08
Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness -
HORIZON-HLTH-2024-DISEASE-03-11
Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society -
HORIZON-HLTH-2024-STAYHLTH-01-02
Access to health and care services for people in vulnerable situations- HORIZON-HLTH-2024-CARE-04-04
The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution -
HORIZON-HLTH-2024-ENVHLTH-02-06
Innovative non-animal human-based tools and strategies for biomedical research -
HORIZON-HLTH-2024-TOOL-05-06
Personalised prevention of non-communicable diseases - addressing areas of unmet needs using multiple data sources -
HORIZON-HLTH-2024-STAYHLTH-01-05
|
Característiques principals
First stage deadline: 19 September 2023 17:00:00 Brussels time
Second stage deadline: 11 April 2024 17:00:00 Brussels time
|
Lloc de presentació
IMIM and PSMAR staff who need more information should contact::
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.: 1670
Marta López: mlopez4@imim.es Ext.: 1576
|
Convocatòria (URL)
https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-4-health_horizon-2023-2024_en.pdf
|
Requisits
Eligibility:
Unless otherwise provided for in the specific call conditions, legal entities forming a consortium are eligible to participate in actions provided that the consortium includes:
at least one independent legal entity established in a Member State; and
at least two other independent legal entities, each established in different Member States or Associated Countries.
|